A randomized trial reports that high-volume injections used to relieve pain and improve function in people with Achilles tendinopathy do not produce benefits beyond sham injections. Patients are assigned to different study arms, and the results show no significant improvement versus placebo treatment.
The trial is described in multiple outlets, with both emphasizing that the injections—commonly used for symptoms such as pain, stiffness, and swelling—fail to show meaningful clinical advantage over a placebo (sham) comparator. One outlet highlights the overall lack of significant benefit in the randomized design, while another frames the finding as “no meaningful benefit” and ties it to the BMJ publication.
Overall, the coverage aligns on the key point that the intervention does not outperform sham treatment, with differences mainly in wording and how directly each outlet connects the result to patient symptom categories and the journal source.
